With untold millions of people worldwide who could benefit from GLP-1 drugs, but unable to afford them, lowering price to boost market share is a way to maximize revenue. Along the way competition between the makers of GLP-1 drugs is also driving down the price of drugs to levels middle class consumers can afford.
Category: Cost of Healthcare
Monday Links – 9 February 2026
- What happens when you quit sugar? (Video)
- Hims & Hers is selling a Wegovy knockoff pill for $49. Novo Nordisk is suing.
- Update on Medicare price negotiations.
- War on poverty update: while poverty fell significantly from 1939 to 1963, the rate of decline was no greater following 1964. Also, almost all of the poverty decline among children and working-age adults was achieved through higher market incomes instead of government support.
- Are CMS star ratings for nursing homes useless?
- Poor people now get about three-fourths of their “income” from government handouts. Back in 1979, the poor actually earned about two-thirds of their income from jobs.
Saturday Links – 7 February 2026
- Site neutral Medicare payment for chemotherapy drugs will save cancer patients up to $1,055 every year.
- Most experts think MFN pricing will not substantially improve patient access to drugs in US.
- Is grandparenting good for the brain?
- Alex Tabarrok: What’s wrong with Trump’s pharmaceutical plan.
- To meet Medicaid’s new work requirements, many states will rely on an Equifax database that covers the wages and work hours of at least 99 million workers. Why does Bernie Sanders have a problem with that? (NYT)
- Claim: More than 80 percent of nurses experience workplace violence each year.
Friday Links – 6 February 2026
- A bad day in Congress for PBMs.
- Does exposure to hip hop music lead to worse outcomes in education, employment, earnings, teen births and single parenthood? No.
- It would take a PCP 27 hours per day to deliver guideline-recommended primary care to a typical panel of patients.
- Hospital merger studies are suspicious, if not fake.
- Money laundering Gavin Newsom style.
- Standing between patients and potentially huge benefits of scientific research: decades of regulatory review and delay.
- The Trump administration really wants you to drink whole milk.